Regeneron Stock - Thursday chart check after May earnings beat
18.06.2026 - 19:06:09 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:05 UTC. Details in the imprint.
Regeneron (US75886F1075) reported a strong first-quarter 2026 earnings beat in early May and its shares have since held close to record territory on the Nasdaq, according to Zacks on 05/23/2026. Zacks recap of Q1 2026 earnings
All news and key data on Regeneron stock
Follow all corporate releases, analyst comments and price data for Regeneron on ad-hoc-news.de and via the company’s own investor-relations pages.
What the latest numbers show
For the first quarter of 2026, Regeneron reported adjusted earnings per share of $9.47, well above the Zacks Consensus Estimate of $8.52 and up from $8.22 a year earlier. Zacks recap of Q1 2026 earnings
Total revenue increased 19% year over year to $3.6 billion, helped by higher sales of Eylea HD and increased profits from the asthma and dermatitis drug Dupixent, according to the same earnings review. Zacks recap of Q1 2026 earnings
Thursday focus on the chart
On Thursday, Regeneron shares are trading around $611 on the Nasdaq, close to recent all-time highs, with eToro quoting $611.07 for REGN, up 0.52% over 24 hours. eToro REGN quote page
Another data provider shows the stock around $610.95, also indicating a modest 0.50% daily gain and confirming a tight trading range near the upper end of its long-term uptrend. OKX REGN price snapshot
The product behind the stock
Regeneron generates most of its revenue from biologic medicines, notably the eye disease treatment Eylea and the anti-inflammatory drug Dupixent, which it co-commercializes with Sanofi across indications such as atopic dermatitis and asthma. Regeneron company information
Where the stock trades today
The shares of Regeneron (US75886F1075) trade on the Nasdaq at about $611.00 as of 06/18/2026, 18:00 UTC.
Key facts on Regeneron stock
- Company: Regeneron Pharmaceuticals Inc.
- ISIN: US75886F1075
- WKN: 881535
- Ticker: REGN
- Venue: Nasdaq
- Price (as of 06/18/2026, 18:00 UTC): 611.00 USD
- Market cap: 63,050,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Biotechnology
- Index membership: Standard & Poor's 500 index
- Next earnings date: 08/01/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
